Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CDC7 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | REL | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | MAFF | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PALB2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | EXOC2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | FXR1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | ARPC4 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SEC14L6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | PSMC4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | CRACR2B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |